Cautious medtech sees surgery rebound
Much delayed and needed elective surgeries are getting back on track as the latest wave of COVID-19 infections eases.
Tag: Healthcare
For vaccine makers, a year of consolidation
It should be another good year, but share prices may have limited upside.
Frustrated cannabis investors eye U.S. for 2022 recovery
With midterm elections causing gridlock, the best hope is for incremental progress toward decriminalization.
Medtronic rattled by Covid resurgence
The healthcare sector offers safety and stability because the companies tend to perform well in all economic conditions.
Will Big Pharma’s Covid vaccine bet pay off?
Drug companies have won praise for a quick rollout of COVID vaccines. Are investors also winners?
Telus, Loblaws see big telehealth future
With the pandemic acting as a catalyst, a spinoff of Telus Health may come sooner rather than later.
Medtech sees 2021 as a year of rebound
Opinions differ on whether recovery will bring on a spending spree.
For pandemic investors Year of the Dog offers opportunity
People have turned to pets for relief from the hard realities of COVID-19. Here are some animal health stocks benefiting from the trend.
3 ways to invest in Canadian telehealth growth
Telus, Loblaws and Well Health Technologies offer a way to capture emerging trends.
Fundamentals favour healthcare sector
Perceptions about Big Pharma have changed as they have turned their resources towards a cure for Covid-19.
Adam Mayers 
You must be logged in to post a comment.